Epizyme Inc
EPZM · Chemicals & Drugs · NASDAQ · in our data May 31, 2013 to August 11, 2022 (9.2 years)
The first trading day in our data for Epizyme Inc is May 31, 2013 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on January 17, 2020, the market valued it at $2.6 billion. It ended in a collapse: the last trade was $1.47, -96.6% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2013. How these numbers are made · Report a data issue.
Could you have seen it coming? Play The Bear of '22Also gone in 2022: Chemicals & Drugs
- Arena Pharmaceuticals Inc peaked at $6.2 billion
- CMC Materials Inc peaked at $5.8 billion
- Global Blood Therapeutics peaked at $5.3 billion
- Clovis Oncology Inc peaked at $4.8 billion
- Chemocentryx Inc peaked at $4.8 billion
- Radius Health Inc peaked at $3.4 billion
